Global Neuroscience Antibodies & Assays Market : Industry Analysis and Forecast (2020-2027) –By Product, Technology, Application, End User,and Region.

Global Neuroscience Antibodies & Assays Market was valued US$ XXBn in 2019 and is expected to grow US$ XXBnby 2027, at a CAGR of 10.3% during the forecast period. Global Neuroscience Antibodies & Assays Market To know about the Research Methodology :- Request Free Sample Report The report study has analyzed the revenue impact of the COVID-19 pandemic on the sales revenue of market leaders, market followers, and market disrupters in the report, and the same is reflected in our analysis. Neuroscience is a heterogeneous field, whichwants coordinated investigation of several organs, tissues, and cell types, utilizing different procedures. The further development in the field of neuroscience will most likely depend on immunodetection and antibodies, given which the researchers will in general expand upon the customary advances instead of abandoning them. Neuroscience contains the study of the nervous system, where the research is dependent on assays & antibodies. These antibodies & assays are specific that helps to detect and examine reactions on the cellular, biochemical, and molecular level. Antibody-based methods are used for the localization, isolation,and characterization of target proteins that majorly used in the cellular and molecular neuroscience. An increasing incidence of neurological illnesses, growing biotechnology and pharmaceutical industries, and increasing investments in neuroscience research are the main factors expected to propel the growth of the neuroscience antibodies & assays market. Also, demand for high-quality antibodies because of the discovery of new potential drug targets, is also expected to push the market. Also, increasing R&D activities are expected to offer innovative growth opportunities for the players functioning in the neuroscience antibodies & assays market, in the future. Alternatively, strict regulatory authorities and reported cases of the adverse immune response against antibodies might impact the global market. By product, the consumables segment is expected to hold the highest CAGR during the forecast period (2020-2027). The consistent usage of consumables and their frequent purchases, and rising government initiatives in the genomics and proteomics research sector are the key factors supporting the growth of the consumables segment of the neuroscience antibodies & assays market. According to end-user, the pharmaceutical and biotechnology companies segment is expected to register the largest market share of the neuroscience antibodies & assays market in 2019. This is mainly attributed to the high uptake of neuroscience antibodies in the drug discovery and development process and government initiatives in the genomics and proteomics research sectors. North America is expected to register for the largest market share of the global neuroscience antibodies & assays market followed by Europe. Though, Asia-Pacific is expected to register the highest CAGR during the forecast period, thanks to factors such as growing research on proteomics and genomics, encouraging funding scenario, and rising incidence of neurological diseases in the Asian region. The objective of the report is to present a comprehensive analysis of the Global Neuroscience Antibodies & Assays Marketincluding all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Neuroscience Antibodies & Assays Marketdynamics, structure by analyzing the market segments and project the Global Neuroscience Antibodies & Assays Marketsize. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Neuroscience Antibodies & Assays Marketmake the report investor’s guide.

Scope of the Global Neuroscience Antibodies & Assays Market: Inquire before buying

Global Neuroscience Antibodies & Assays Market, By Product

• Consumables o Reagents  Media & Sera  Stains & Dyes  Fixatives  Buffers  Solvents  Probes  Enzymes, Proteins, & Peptides  Other Reagents o Antibodies  Primary antibodies  Secondary Antibodies o Assay Kits • Instruments o Microplate Readers o Immunoassay Analyzers o Other Instruments

Global Neuroscience Antibodies & Assays Market, By Technology

• Immunochemistry/Immunoassays o ELISA o Western Blotting o Others Immunoassays Technologies • Molecular Diagnostics • Clinical Chemistry • Other Technologies

Global Neuroscience Antibodies & Assays Market, By Application

• Research • In Vitro Diagnostics • Drug Discovery and Development

Global Neuroscience Antibodies & Assays Market, By End User

• Pharmaceutical & Biotechnology Companies • Academic & Research Institutes • Hospitals & Diagnostic Centers

Global Neuroscience Antibodies & Assays Market, By Region

• North America • Europe • Asia Pacific • Middle East & Africa • South America

Key players operating in the Global Neuroscience Antibodies & Assays Market

• Thermo Fisher Scientific • Abcam • Bio-Rad • Merck KGaA • BioLegend • Cell Signaling Technology • F. Hoffmann-La Roche • GenScript • Rockland Immunochemicals • Santa Cruz Biotechnology • Siemens • Tecan • Others

Global Neuroscience Antibodies & Assays Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Neuroscience Antibodies & Assays Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Neuroscience Antibodies & Assays Market Analysis and Forecast 6.1. Neuroscience Antibodies & Assays Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Neuroscience Antibodies & Assays Market Analysis and Forecast, By Product 7.1. Introduction and Definition 7.2. Key Findings 7.3. Neuroscience Antibodies & Assays Market Value Share Analysis, By Product 7.4. Neuroscience Antibodies & Assays Market Size (US$ Bn) Forecast, By Product 7.5. Neuroscience Antibodies & Assays Market Analysis, By Product 7.6. Neuroscience Antibodies & Assays Market Attractiveness Analysis, By Product 8. Global Neuroscience Antibodies & Assays Market Analysis and Forecast, by End-user 8.1. Introduction and Definition 8.2. Key Findings 8.3. Neuroscience Antibodies & Assays Market Value Share Analysis, by End-user 8.4. Neuroscience Antibodies & Assays Market Size (US$ Bn) Forecast, by End-user 8.5. Neuroscience Antibodies & Assays Market Analysis, by End-user 8.6. Neuroscience Antibodies & Assays Market Attractiveness Analysis, by End-user 9. Global Neuroscience Antibodies & Assays Market Analysis and Forecast, By Technology 9.1. Introduction and Definition 9.2. Key Findings 9.3. Neuroscience Antibodies & Assays Market Value Share Analysis, By Technology 9.4. Neuroscience Antibodies & Assays Market Size (US$ Bn) Forecast, By Technology 9.5. Neuroscience Antibodies & Assays Market Analysis, By Technology 9.6. Neuroscience Antibodies & Assays Market Attractiveness Analysis, By Technology 10. Global Neuroscience Antibodies & Assays Market Analysis and Forecast, By Application 10.1. Introduction and Definition 10.2. Key Findings 10.3. Neuroscience Antibodies & Assays Market Value Share Analysis, By Application 10.4. Neuroscience Antibodies & Assays Market Size (US$ Bn) Forecast, By Application 10.5. Neuroscience Antibodies & Assays Market Analysis, By Application 10.6. Neuroscience Antibodies & Assays Market Attractiveness Analysis, By Application 11. Global Neuroscience Antibodies & Assays Market Analysis, by Region 11.1. Neuroscience Antibodies & Assays Market Value Share Analysis, by Region 11.2. Neuroscience Antibodies & Assays Market Size (US$ Bn) Forecast, by Region 11.3. Neuroscience Antibodies & Assays Market Attractiveness Analysis, by Region 12. North America Neuroscience Antibodies & Assays Market Analysis 12.1. Key Findings 12.2. North America Neuroscience Antibodies & Assays Market Overview 12.3. North America Neuroscience Antibodies & Assays Market Value Share Analysis, By Product 12.4. North America Neuroscience Antibodies & Assays Market Forecast, By Product 12.4.1. Consumables 12.4.1.1. Reagents 12.4.1.1.1. Media & Sera 12.4.1.1.2. Stains & Dyes 12.4.1.1.3. Fixatives 12.4.1.1.4. Buffers 12.4.1.1.5. Solvents 12.4.1.1.6. Probes 12.4.1.1.7. Enzymes, Proteins, & Peptides 12.4.1.1.8. Other Reagents 12.4.1.2. Antibodies 12.4.1.2.1. Primary antibodies 12.4.1.2.2. Secondary Antibodies 12.4.1.3. Assay Kits 12.4.2. Instruments 12.4.2.1. Microplate Readers 12.4.2.2. Immunoassay Analyzers 12.4.2.3. Other Instruments 12.5. North America Neuroscience Antibodies & Assays Market Value Share Analysis, by End-user 12.6. North America Neuroscience Antibodies & Assays Market Forecast, by End-user 12.6.1. Pharmaceutical & Biotechnology Companies 12.6.2. Academic & Research Institutes 12.6.3. Hospitals & Diagnostic Centers 12.7. North America Neuroscience Antibodies & Assays Market Value Share Analysis, By Technology 12.8. North America Neuroscience Antibodies & Assays Market Forecast, By Technology 12.8.1. Immunochemistry/Immunoassays 12.8.1.1. ELISA 12.8.1.2. Western Blotting 12.8.1.3. Others Immunoassays Technologies 12.8.2. Molecular Diagnostics 12.8.3. Clinical Chemistry 12.8.4. Other Technologies 12.9. North America Neuroscience Antibodies & Assays Market Value Share Analysis, By Application 12.10. North America Neuroscience Antibodies & Assays Market Forecast, By Application 12.10.1. Research 12.10.2. In Vitro Diagnostics 12.10.3. Drug Discovery and Development 12.11. North America Neuroscience Antibodies & Assays Market Value Share Analysis, by Country 12.12. North America Neuroscience Antibodies & Assays Market Forecast, by Country 12.12.1. U.S. 12.12.2. Canada 12.13. North America Neuroscience Antibodies & Assays Market Analysis, by Country 12.14. U.S. Neuroscience Antibodies & Assays Market Forecast, By Product 12.14.1. Consumables 12.14.1.1. Reagents 12.14.1.1.1. Media & Sera 12.14.1.1.2. Stains & Dyes 12.14.1.1.3. Fixatives 12.14.1.1.4. Buffers 12.14.1.1.5. Solvents 12.14.1.1.6. Probes 12.14.1.1.7. Enzymes, Proteins, & Peptides 12.14.1.1.8. Other Reagents 12.14.1.2. Antibodies 12.14.1.2.1. Primary antibodies 12.14.1.2.2. Secondary Antibodies 12.14.1.3. Assay Kits 12.14.2. Instruments 12.14.2.1. Microplate Readers 12.14.2.2. Immunoassay Analyzers 12.14.2.3. Other Instruments 12.15. U.S. Neuroscience Antibodies & Assays Market Forecast, by End-user 12.15.1. Pharmaceutical & Biotechnology Companies 12.15.2. Academic & Research Institutes 12.15.3. Hospitals & Diagnostic Centers 12.16. U.S. Neuroscience Antibodies & Assays Market Forecast, By Technology 12.16.1. Immunochemistry/Immunoassays 12.16.1.1. ELISA 12.16.1.2. Western Blotting 12.16.1.3. Others Immunoassays Technologies 12.16.2. Molecular Diagnostics 12.16.3. Clinical Chemistry 12.16.4. Other Technologies 12.17. U.S. Neuroscience Antibodies & Assays Market Forecast, By Application 12.17.1. Research 12.17.2. In Vitro Diagnostics 12.17.3. Drug Discovery and Development 12.18. Canada Neuroscience Antibodies & Assays Market Forecast, By Product 12.18.1. Consumables 12.18.1.1. Reagents 12.18.1.1.1. Media & Sera 12.18.1.1.2. Stains & Dyes 12.18.1.1.3. Fixatives 12.18.1.1.4. Buffers 12.18.1.1.5. Solvents 12.18.1.1.6. Probes 12.18.1.1.7. Enzymes, Proteins, & Peptides 12.18.1.1.8. Other Reagents 12.18.1.2. Antibodies 12.18.1.2.1. Primary antibodies 12.18.1.2.2. Secondary Antibodies 12.18.1.3. Assay Kits 12.18.2. Instruments 12.18.2.1. Microplate Readers 12.18.2.2. Immunoassay Analyzers 12.18.2.3. Other Instruments 12.19. Canada Neuroscience Antibodies & Assays Market Forecast, by End-user 12.19.1. Pharmaceutical & Biotechnology Companies 12.19.2. Academic & Research Institutes 12.19.3. Hospitals & Diagnostic Centers 12.20. Canada Neuroscience Antibodies & Assays Market Forecast, By Technology 12.20.1. Immunochemistry/Immunoassays 12.20.1.1. ELISA 12.20.1.2. Western Blotting 12.20.1.3. Others Immunoassays Technologies 12.20.2. Molecular Diagnostics 12.20.3. Clinical Chemistry 12.20.4. Other Technologies 12.21. Canada Neuroscience Antibodies & Assays Market Forecast, By Application 12.21.1. Research 12.21.2. In Vitro Diagnostics 12.21.3. Drug Discovery and Development 12.22. North America Neuroscience Antibodies & Assays Market Attractiveness Analysis 12.22.1. By Product 12.22.2. By End-user 12.22.3. By Technology 12.22.4. By Application 12.23. PEST Analysis 12.24. Key Trends 12.25. Key Developments 13. Europe Neuroscience Antibodies & Assays Market Analysis 13.1. Key Findings 13.2. Europe Neuroscience Antibodies & Assays Market Overview 13.3. Europe Neuroscience Antibodies & Assays Market Value Share Analysis, By Product 13.4. Europe Neuroscience Antibodies & Assays Market Forecast, By Product 13.4.1. Consumables 13.4.1.1. Reagents 13.4.1.1.1. Media & Sera 13.4.1.1.2. Stains & Dyes 13.4.1.1.3. Fixatives 13.4.1.1.4. Buffers 13.4.1.1.5. Solvents 13.4.1.1.6. Probes 13.4.1.1.7. Enzymes, Proteins, & Peptides 13.4.1.1.8. Other Reagents 13.4.1.2. Antibodies 13.4.1.2.1. Primary antibodies 13.4.1.2.2. Secondary Antibodies 13.4.1.3. Assay Kits 13.4.2. Instruments 13.4.2.1. Microplate Readers 13.4.2.2. Immunoassay Analyzers 13.4.2.3. Other Instruments 13.5. Europe Neuroscience Antibodies & Assays Market Value Share Analysis, by End-user 13.6. Europe Neuroscience Antibodies & Assays Market Forecast, by End-user 13.6.1. Pharmaceutical & Biotechnology Companies 13.6.2. Academic & Research Institutes 13.6.3. Hospitals & Diagnostic Centers 13.7. Europe Neuroscience Antibodies & Assays Market Value Share Analysis, By Technology 13.8. Europe Neuroscience Antibodies & Assays Market Forecast, By Technology 13.8.1. Immunochemistry/Immunoassays 13.8.1.1. ELISA 13.8.1.2. Western Blotting 13.8.1.3. Others Immunoassays Technologies 13.8.2. Molecular Diagnostics 13.8.3. Clinical Chemistry 13.8.4. Other Technologies 13.9. Europe Neuroscience Antibodies & Assays Market Value Share Analysis, By Application 13.10. Europe Neuroscience Antibodies & Assays Market Forecast, By Application 13.10.1. Research 13.10.2. In Vitro Diagnostics 13.10.3. Drug Discovery and Development 13.11. Europe Neuroscience Antibodies & Assays Market Value Share Analysis, by Country 13.12. Europe Neuroscience Antibodies & Assays Market Forecast, by Country 13.12.1. Germany 13.12.2. U.K. 13.12.3. France 13.12.4. Italy 13.12.5. Spain 13.12.6. Norway 13.12.7. Russia 13.13. Europe Neuroscience Antibodies & Assays Market Analysis, by Country 13.14. Germany Neuroscience Antibodies & Assays Market Forecast, By Product 13.14.1. Consumables 13.14.1.1. Reagents 13.14.1.1.1. Media & Sera 13.14.1.1.2. Stains & Dyes 13.14.1.1.3. Fixatives 13.14.1.1.4. Buffers 13.14.1.1.5. Solvents 13.14.1.1.6. Probes 13.14.1.1.7. Enzymes, Proteins, & Peptides 13.14.1.1.8. Other Reagents 13.14.1.2. Antibodies 13.14.1.2.1. Primary antibodies 13.14.1.2.2. Secondary Antibodies 13.14.1.3. Assay Kits 13.14.2. Instruments 13.14.2.1. Microplate Readers 13.14.2.2. Immunoassay Analyzers 13.14.2.3. Other Instruments 13.15. Germany Neuroscience Antibodies & Assays Market Forecast, by End-user 13.15.1. Pharmaceutical & Biotechnology Companies 13.15.2. Academic & Research Institutes 13.15.3. Hospitals & Diagnostic Centers 13.16. Germany Neuroscience Antibodies & Assays Market Forecast, By Technology 13.16.1. Immunochemistry/Immunoassays 13.16.1.1. ELISA 13.16.1.2. Western Blotting 13.16.1.3. Others Immunoassays Technologies 13.16.2. Molecular Diagnostics 13.16.3. Clinical Chemistry 13.16.4. Other Technologies 13.17. Germany Neuroscience Antibodies & Assays Market Forecast, By Application 13.17.1. Research 13.17.2. In Vitro Diagnostics 13.17.3. Drug Discovery and Development 13.18. U.K. Neuroscience Antibodies & Assays Market Forecast, By Product 13.18.1. Consumables 13.18.1.1. Reagents 13.18.1.1.1. Media & Sera 13.18.1.1.2. Stains & Dyes 13.18.1.1.3. Fixatives 13.18.1.1.4. Buffers 13.18.1.1.5. Solvents 13.18.1.1.6. Probes 13.18.1.1.7. Enzymes, Proteins, & Peptides 13.18.1.1.8. Other Reagents 13.18.1.2. Antibodies 13.18.1.2.1. Primary antibodies 13.18.1.2.2. Secondary Antibodies 13.18.1.3. Assay Kits 13.18.2. Instruments 13.18.2.1. Microplate Readers 13.18.2.2. Immunoassay Analyzers 13.18.2.3. Other Instruments 13.19. U.K. Neuroscience Antibodies & Assays Market Forecast, by End-user 13.19.1. Pharmaceutical & Biotechnology Companies 13.19.2. Academic & Research Institutes 13.19.3. Hospitals & Diagnostic Centers 13.20. U.K. Neuroscience Antibodies & Assays Market Forecast, By Technology 13.20.1. Immunochemistry/Immunoassays 13.20.1.1. ELISA 13.20.1.2. Western Blotting 13.20.1.3. Others Immunoassays Technologies 13.20.2. Molecular Diagnostics 13.20.3. Clinical Chemistry 13.20.4. Other Technologies 13.21. U.K. Neuroscience Antibodies & Assays Market Forecast, By Application 13.21.1. Research 13.21.2. In Vitro Diagnostics 13.21.3. Drug Discovery and Development 13.22. France Neuroscience Antibodies & Assays Market Forecast, By Product 13.22.1. Consumables 13.22.1.1. Reagents 13.22.1.1.1. Media & Sera 13.22.1.1.2. Stains & Dyes 13.22.1.1.3. Fixatives 13.22.1.1.4. Buffers 13.22.1.1.5. Solvents 13.22.1.1.6. Probes 13.22.1.1.7. Enzymes, Proteins, & Peptides 13.22.1.1.8. Other Reagents 13.22.1.2. Antibodies 13.22.1.2.1. Primary antibodies 13.22.1.2.2. Secondary Antibodies 13.22.1.3. Assay Kits 13.22.2. Instruments 13.22.2.1. Microplate Readers 13.22.2.2. Immunoassay Analyzers 13.22.2.3. Other Instruments 13.23. France Neuroscience Antibodies & Assays Market Forecast, by End-user 13.23.1. Pharmaceutical & Biotechnology Companies 13.23.2. Academic & Research Institutes 13.23.3. Hospitals & Diagnostic Centers 13.24. France Neuroscience Antibodies & Assays Market Forecast, By Technology 13.24.1. Immunochemistry/Immunoassays 13.24.1.1. ELISA 13.24.1.2. Western Blotting 13.24.1.3. Others Immunoassays Technologies 13.24.2. Molecular Diagnostics 13.24.3. Clinical Chemistry 13.24.4. Other Technologies 13.25. France Neuroscience Antibodies & Assays Market Forecast, By Application 13.25.1. Research 13.25.2. In Vitro Diagnostics 13.25.3. Drug Discovery and Development 13.26. Italy Neuroscience Antibodies & Assays Market Forecast, By Product 13.26.1. Consumables 13.26.1.1. Reagents 13.26.1.1.1. Media & Sera 13.26.1.1.2. Stains & Dyes 13.26.1.1.3. Fixatives 13.26.1.1.4. Buffers 13.26.1.1.5. Solvents 13.26.1.1.6. Probes 13.26.1.1.7. Enzymes, Proteins, & Peptides 13.26.1.1.8. Other Reagents 13.26.1.2. Antibodies 13.26.1.2.1. Primary antibodies 13.26.1.2.2. Secondary Antibodies 13.26.1.3. Assay Kits 13.26.2. Instruments 13.26.2.1. Microplate Readers 13.26.2.2. Immunoassay Analyzers 13.26.2.3. Other Instruments 13.27. Italy Neuroscience Antibodies & Assays Market Forecast, by End-user 13.27.1. Pharmaceutical & Biotechnology Companies 13.27.2. Academic & Research Institutes 13.27.3. Hospitals & Diagnostic Centers 13.28. Italy Neuroscience Antibodies & Assays Market Forecast, By Technology 13.28.1. Immunochemistry/Immunoassays 13.28.1.1. ELISA 13.28.1.2. Western Blotting 13.28.1.3. Others Immunoassays Technologies 13.28.2. Molecular Diagnostics 13.28.3. Clinical Chemistry 13.28.4. Other Technologies 13.29. Italy Neuroscience Antibodies & Assays Market Forecast, By Application 13.29.1. Research 13.29.2. In Vitro Diagnostics 13.29.3. Drug Discovery and Development 13.30. SpainNeuroscience Antibodies & Assays Market Forecast, By Product 13.30.1. Consumables 13.30.1.1. Reagents 13.30.1.1.1. Media & Sera 13.30.1.1.2. Stains & Dyes 13.30.1.1.3. Fixatives 13.30.1.1.4. Buffers 13.30.1.1.5. Solvents 13.30.1.1.6. Probes 13.30.1.1.7. Enzymes, Proteins, & Peptides 13.30.1.1.8. Other Reagents 13.30.1.2. Antibodies 13.30.1.2.1. Primary antibodies 13.30.1.2.2. Secondary Antibodies 13.30.1.3. Assay Kits 13.30.2. Instruments 13.30.2.1. Microplate Readers 13.30.2.2. Immunoassay Analyzers 13.30.2.3. Other Instruments 13.31. SpainNeuroscience Antibodies & Assays Market Forecast, by End-user 13.31.1. Pharmaceutical & Biotechnology Companies 13.31.2. Academic & Research Institutes 13.31.3. Hospitals & Diagnostic Centers 13.32. SpainNeuroscience Antibodies & Assays Market Forecast, By Technology 13.32.1. Immunochemistry/Immunoassays 13.32.1.1. ELISA 13.32.1.2. Western Blotting 13.32.1.3. Others Immunoassays Technologies 13.32.2. Molecular Diagnostics 13.32.3. Clinical Chemistry 13.32.4. Other Technologies 13.33. SpainNeuroscience Antibodies & Assays Market Forecast, By Application 13.33.1. Research 13.33.2. In Vitro Diagnostics 13.33.3. Drug Discovery and Development 13.34. NorwayNeuroscience Antibodies & Assays Market Forecast, By Product 13.34.1. Consumables 13.34.1.1. Reagents 13.34.1.1.1. Media & Sera 13.34.1.1.2. Stains & Dyes 13.34.1.1.3. Fixatives 13.34.1.1.4. Buffers 13.34.1.1.5. Solvents 13.34.1.1.6. Probes 13.34.1.1.7. Enzymes, Proteins, & Peptides 13.34.1.1.8. Other Reagents 13.34.1.2. Antibodies 13.34.1.2.1. Primary antibodies 13.34.1.2.2. Secondary Antibodies 13.34.1.3. Assay Kits 13.34.2. Instruments 13.34.2.1. Microplate Readers 13.34.2.2. Immunoassay Analyzers 13.34.2.3. Other Instruments 13.35. NorwayNeuroscience Antibodies & Assays Market Forecast, by End-user 13.35.1. Pharmaceutical & Biotechnology Companies 13.35.2. Academic & Research Institutes 13.35.3. Hospitals & Diagnostic Centers 13.36. NorwayNeuroscience Antibodies & Assays Market Forecast, By Technology 13.36.1. Immunochemistry/Immunoassays 13.36.1.1. ELISA 13.36.1.2. Western Blotting 13.36.1.3. Others Immunoassays Technologies 13.36.2. Molecular Diagnostics 13.36.3. Clinical Chemistry 13.36.4. Other Technologies 13.37. NorwayNeuroscience Antibodies & Assays Market Forecast, By Application 13.37.1. Research 13.37.2. In Vitro Diagnostics 13.37.3. Drug Discovery and Development 13.38. RussiaNeuroscience Antibodies & Assays Market Forecast, By Product 13.38.1. Consumables 13.38.1.1. Reagents 13.38.1.1.1. Media & Sera 13.38.1.1.2. Stains & Dyes 13.38.1.1.3. Fixatives 13.38.1.1.4. Buffers 13.38.1.1.5. Solvents 13.38.1.1.6. Probes 13.38.1.1.7. Enzymes, Proteins, & Peptides 13.38.1.1.8. Other Reagents 13.38.1.2. Antibodies 13.38.1.2.1. Primary antibodies 13.38.1.2.2. Secondary Antibodies 13.38.1.3. Assay Kits 13.38.2. Instruments 13.38.2.1. Microplate Readers 13.38.2.2. Immunoassay Analyzers 13.38.2.3. Other Instruments 13.39. RussiaNeuroscience Antibodies & Assays Market Forecast, by End-user 13.39.1. Pharmaceutical & Biotechnology Companies 13.39.2. Academic & Research Institutes 13.39.3. Hospitals & Diagnostic Centers 13.40. RussiaNeuroscience Antibodies & Assays Market Forecast, By Technology 13.40.1. Immunochemistry/Immunoassays 13.40.1.1. ELISA 13.40.1.2. Western Blotting 13.40.1.3. Others Immunoassays Technologies 13.40.2. Molecular Diagnostics 13.40.3. Clinical Chemistry 13.40.4. Other Technologies 13.41. RussiaNeuroscience Antibodies & Assays Market Forecast, By Application 13.41.1. Research 13.41.2. In Vitro Diagnostics 13.41.3. Drug Discovery and Development 13.42. Europe Neuroscience Antibodies & Assays Market Attractiveness Analysis 13.42.1. By Product 13.42.2. By End-user 13.42.3. By Technology 13.42.4. By Application 13.43. PEST Analysis 13.44. Key Trends 13.45. Key Developments 14. Asia Pacific Neuroscience Antibodies & Assays Market Analysis 14.1. Key Findings 14.2. Asia Pacific Neuroscience Antibodies & Assays Market Overview 14.3. Asia Pacific Neuroscience Antibodies & Assays Market Value Share Analysis, By Product 14.4. Asia Pacific Neuroscience Antibodies & Assays Market Forecast, By Product 14.4.1. Consumables 14.4.1.1. Reagents 14.4.1.1.1. Media & Sera 14.4.1.1.2. Stains & Dyes 14.4.1.1.3. Fixatives 14.4.1.1.4. Buffers 14.4.1.1.5. Solvents 14.4.1.1.6. Probes 14.4.1.1.7. Enzymes, Proteins, & Peptides 14.4.1.1.8. Other Reagents 14.4.1.2. Antibodies 14.4.1.2.1. Primary antibodies 14.4.1.2.2. Secondary Antibodies 14.4.1.3. Assay Kits 14.4.2. Instruments 14.4.2.1. Microplate Readers 14.4.2.2. Immunoassay Analyzers 14.4.2.3. Other Instruments 14.5. Asia Pacific Neuroscience Antibodies & Assays Market Value Share Analysis, by End-user 14.6. Asia Pacific Neuroscience Antibodies & Assays Market Forecast, by End-user 14.6.1. Pharmaceutical & Biotechnology Companies 14.6.2. Academic & Research Institutes 14.6.3. Hospitals & Diagnostic Centers 14.7. Asia Pacific Neuroscience Antibodies & Assays Market Value Share Analysis, By Technology 14.8. Asia Pacific Neuroscience Antibodies & Assays Market Forecast, By Technology 14.8.1. Immunochemistry/Immunoassays 14.8.1.1. ELISA 14.8.1.2. Western Blotting 14.8.1.3. Others Immunoassays Technologies 14.8.2. Molecular Diagnostics 14.8.3. Clinical Chemistry 14.8.4. Other Technologies 14.9. Asia Pacific Neuroscience Antibodies & Assays Market Value Share Analysis, By Application 14.10. Asia Pacific Neuroscience Antibodies & Assays Market Forecast, By Application 14.10.1. Research 14.10.2. In Vitro Diagnostics 14.10.3. Drug Discovery and Development 14.11. Asia Pacific Neuroscience Antibodies & Assays Market Value Share Analysis, by Country 14.12. Asia Pacific Neuroscience Antibodies & Assays Market Forecast, by Country 14.12.1. China 14.12.2. India 14.12.3. Japan 14.12.4. South Korea 14.12.5. Australia 14.12.6. Malaysia 14.12.7. Indonesia 14.12.8. Vietnam 14.13. Asia Pacific Neuroscience Antibodies & Assays Market Analysis, by Country 14.14. China Neuroscience Antibodies & Assays Market Forecast, By Product 14.14.1. Consumables 14.14.1.1. Reagents 14.14.1.1.1. Media & Sera 14.14.1.1.2. Stains & Dyes 14.14.1.1.3. Fixatives 14.14.1.1.4. Buffers 14.14.1.1.5. Solvents 14.14.1.1.6. Probes 14.14.1.1.7. Enzymes, Proteins, & Peptides 14.14.1.1.8. Other Reagents 14.14.1.2. Antibodies 14.14.1.2.1. Primary antibodies 14.14.1.2.2. Secondary Antibodies 14.14.1.3. Assay Kits 14.14.2. Instruments 14.14.2.1. Microplate Readers 14.14.2.2. Immunoassay Analyzers 14.14.2.3. Other Instruments 14.15. China Neuroscience Antibodies & Assays Market Forecast, by End-user 14.15.1. Pharmaceutical & Biotechnology Companies 14.15.2. Academic & Research Institutes 14.15.3. Hospitals & Diagnostic Centers 14.16. China Neuroscience Antibodies & Assays Market Forecast, By Technology 14.16.1. Immunochemistry/Immunoassays 14.16.1.1. ELISA 14.16.1.2. Western Blotting 14.16.1.3. Others Immunoassays Technologies 14.16.2. Molecular Diagnostics 14.16.3. Clinical Chemistry 14.16.4. Other Technologies 14.17. China Neuroscience Antibodies & Assays Market Forecast, By Application 14.17.1. Research 14.17.2. In Vitro Diagnostics 14.17.3. Drug Discovery and Development 14.18. India Neuroscience Antibodies & Assays Market Forecast, By Product 14.18.1. Consumables 14.18.1.1. Reagents 14.18.1.1.1. Media & Sera 14.18.1.1.2. Stains & Dyes 14.18.1.1.3. Fixatives 14.18.1.1.4. Buffers 14.18.1.1.5. Solvents 14.18.1.1.6. Probes 14.18.1.1.7. Enzymes, Proteins, & Peptides 14.18.1.1.8. Other Reagents 14.18.1.2. Antibodies 14.18.1.2.1. Primary antibodies 14.18.1.2.2. Secondary Antibodies 14.18.1.3. Assay Kits 14.18.2. Instruments 14.18.2.1. Microplate Readers 14.18.2.2. Immunoassay Analyzers 14.18.2.3. Other Instruments 14.19. India Neuroscience Antibodies & Assays Market Forecast, by End-user 14.19.1. Pharmaceutical & Biotechnology Companies 14.19.2. Academic & Research Institutes 14.19.3. Hospitals & Diagnostic Centers 14.20. India Neuroscience Antibodies & Assays Market Forecast, By Technology 14.20.1. Immunochemistry/Immunoassays 14.20.1.1. ELISA 14.20.1.2. Western Blotting 14.20.1.3. Others Immunoassays Technologies 14.20.2. Molecular Diagnostics 14.20.3. Clinical Chemistry 14.20.4. Other Technologies 14.21. India Neuroscience Antibodies & Assays Market Forecast, By Application 14.21.1. Research 14.21.2. In Vitro Diagnostics 14.21.3. Drug Discovery and Development 14.22. Japan Neuroscience Antibodies & Assays Market Forecast, By Product 14.22.1. Consumables 14.22.1.1. Reagents 14.22.1.1.1. Media & Sera 14.22.1.1.2. Stains & Dyes 14.22.1.1.3. Fixatives 14.22.1.1.4. Buffers 14.22.1.1.5. Solvents 14.22.1.1.6. Probes 14.22.1.1.7. Enzymes, Proteins, & Peptides 14.22.1.1.8. Other Reagents 14.22.1.2. Antibodies 14.22.1.2.1. Primary antibodies 14.22.1.2.2. Secondary Antibodies 14.22.1.3. Assay Kits 14.22.2. Instruments 14.22.2.1. Microplate Readers 14.22.2.2. Immunoassay Analyzers 14.22.2.3. Other Instruments 14.23. Japan Neuroscience Antibodies & Assays Market Forecast, by End-user 14.23.1. Pharmaceutical & Biotechnology Companies 14.23.2. Academic & Research Institutes 14.23.3. Hospitals & Diagnostic Centers 14.24. Japan Neuroscience Antibodies & Assays Market Forecast, By Technology 14.24.1. Immunochemistry/Immunoassays 14.24.1.1. ELISA 14.24.1.2. Western Blotting 14.24.1.3. Others Immunoassays Technologies 14.24.2. Molecular Diagnostics 14.24.3. Clinical Chemistry 14.24.4. Other Technologies 14.25. Japan Neuroscience Antibodies & Assays Market Forecast, By Application 14.25.1. Research 14.25.2. In Vitro Diagnostics 14.25.3. Drug Discovery and Development 14.26. South KoreaNeuroscience Antibodies & Assays Market Forecast, By Product 14.26.1. Consumables 14.26.1.1. Reagents 14.26.1.1.1. Media & Sera 14.26.1.1.2. Stains & Dyes 14.26.1.1.3. Fixatives 14.26.1.1.4. Buffers 14.26.1.1.5. Solvents 14.26.1.1.6. Probes 14.26.1.1.7. Enzymes, Proteins, & Peptides 14.26.1.1.8. Other Reagents 14.26.1.2. Antibodies 14.26.1.2.1. Primary antibodies 14.26.1.2.2. Secondary Antibodies 14.26.1.3. Assay Kits 14.26.2. Instruments 14.26.2.1. Microplate Readers 14.26.2.2. Immunoassay Analyzers 14.26.2.3. Other Instruments 14.27. South KoreaNeuroscience Antibodies & Assays Market Forecast, by End-user 14.27.1. Pharmaceutical & Biotechnology Companies 14.27.2. Academic & Research Institutes 14.27.3. Hospitals & Diagnostic Centers 14.28. South KoreaNeuroscience Antibodies & Assays Market Forecast, By Technology 14.28.1. Immunochemistry/Immunoassays 14.28.1.1. ELISA 14.28.1.2. Western Blotting 14.28.1.3. Others Immunoassays Technologies 14.28.2. Molecular Diagnostics 14.28.3. Clinical Chemistry 14.28.4. Other Technologies 14.29. South KoreaNeuroscience Antibodies & Assays Market Forecast, By Application 14.29.1. Research 14.29.2. In Vitro Diagnostics 14.29.3. Drug Discovery and Development 14.30. AustraliaNeuroscience Antibodies & Assays Market Forecast, By Product 14.30.1. Consumables 14.30.1.1. Reagents 14.30.1.1.1. Media & Sera 14.30.1.1.2. Stains & Dyes 14.30.1.1.3. Fixatives 14.30.1.1.4. Buffers 14.30.1.1.5. Solvents 14.30.1.1.6. Probes 14.30.1.1.7. Enzymes, Proteins, & Peptides 14.30.1.1.8. Other Reagents 14.30.1.2. Antibodies 14.30.1.2.1. Primary antibodies 14.30.1.2.2. Secondary Antibodies 14.30.1.3. Assay Kits 14.30.2. Instruments 14.30.2.1. Microplate Readers 14.30.2.2. Immunoassay Analyzers 14.30.2.3. Other Instruments 14.31. AustraliaNeuroscience Antibodies & Assays Market Forecast, by End-user 14.31.1. Pharmaceutical & Biotechnology Companies 14.31.2. Academic & Research Institutes 14.31.3. Hospitals & Diagnostic Centers 14.32. AustraliaNeuroscience Antibodies & Assays Market Forecast, By Technology 14.32.1. Immunochemistry/Immunoassays 14.32.1.1. ELISA 14.32.1.2. Western Blotting 14.32.1.3. Others Immunoassays Technologies 14.32.2. Molecular Diagnostics 14.32.3. Clinical Chemistry 14.32.4. Other Technologies 14.33. AustraliaNeuroscience Antibodies & Assays Market Forecast, By Application 14.33.1. Research 14.33.2. In Vitro Diagnostics 14.33.3. Drug Discovery and Development 14.34. MalaysiaNeuroscience Antibodies & Assays Market Forecast, By Product 14.34.1. Consumables 14.34.1.1. Reagents 14.34.1.1.1. Media & Sera 14.34.1.1.2. Stains & Dyes 14.34.1.1.3. Fixatives 14.34.1.1.4. Buffers 14.34.1.1.5. Solvents 14.34.1.1.6. Probes 14.34.1.1.7. Enzymes, Proteins, & Peptides 14.34.1.1.8. Other Reagents 14.34.1.2. Antibodies 14.34.1.2.1. Primary antibodies 14.34.1.2.2. Secondary Antibodies 14.34.1.3. Assay Kits 14.34.2. Instruments 14.34.2.1. Microplate Readers 14.34.2.2. Immunoassay Analyzers 14.34.2.3. Other Instruments 14.35. MalaysiaNeuroscience Antibodies & Assays Market Forecast, by End-user 14.35.1. Pharmaceutical & Biotechnology Companies 14.35.2. Academic & Research Institutes 14.35.3. Hospitals & Diagnostic Centers 14.36. MalaysiaNeuroscience Antibodies & Assays Market Forecast, By Technology 14.36.1. Immunochemistry/Immunoassays 14.36.1.1. ELISA 14.36.1.2. Western Blotting 14.36.1.3. Others Immunoassays Technologies 14.36.2. Molecular Diagnostics 14.36.3. Clinical Chemistry 14.36.4. Other Technologies 14.37. MalaysiaNeuroscience Antibodies & Assays Market Forecast, By Application 14.37.1. Research 14.37.2. In Vitro Diagnostics 14.37.3. Drug Discovery and Development 14.38. IndonesiaNeuroscience Antibodies & Assays Market Forecast, By Product 14.38.1. Consumables 14.38.1.1. Reagents 14.38.1.1.1. Media & Sera 14.38.1.1.2. Stains & Dyes 14.38.1.1.3. Fixatives 14.38.1.1.4. Buffers 14.38.1.1.5. Solvents 14.38.1.1.6. Probes 14.38.1.1.7. Enzymes, Proteins, & Peptides 14.38.1.1.8. Other Reagents 14.38.1.2. Antibodies 14.38.1.2.1. Primary antibodies 14.38.1.2.2. Secondary Antibodies 14.38.1.3. Assay Kits 14.38.2. Instruments 14.38.2.1. Microplate Readers 14.38.2.2. Immunoassay Analyzers 14.38.2.3. Other Instruments 14.39. IndonesiaNeuroscience Antibodies & Assays Market Forecast, by End-user 14.39.1. Pharmaceutical & Biotechnology Companies 14.39.2. Academic & Research Institutes 14.39.3. Hospitals & Diagnostic Centers 14.40. IndonesiaNeuroscience Antibodies & Assays Market Forecast, By Technology 14.40.1. Immunochemistry/Immunoassays 14.40.1.1. ELISA 14.40.1.2. Western Blotting 14.40.1.3. Others Immunoassays Technologies 14.40.2. Molecular Diagnostics 14.40.3. Clinical Chemistry 14.40.4. Other Technologies 14.41. IndonesiaNeuroscience Antibodies & Assays Market Forecast, By Application 14.41.1. Research 14.41.2. In Vitro Diagnostics 14.41.3. Drug Discovery and Development 14.42. VietnamNeuroscience Antibodies & Assays Market Forecast, By Product 14.42.1. Consumables 14.42.1.1. Reagents 14.42.1.1.1. Media & Sera 14.42.1.1.2. Stains & Dyes 14.42.1.1.3. Fixatives 14.42.1.1.4. Buffers 14.42.1.1.5. Solvents 14.42.1.1.6. Probes 14.42.1.1.7. Enzymes, Proteins, & Peptides 14.42.1.1.8. Other Reagents 14.42.1.2. Antibodies 14.42.1.2.1. Primary antibodies 14.42.1.2.2. Secondary Antibodies 14.42.1.3. Assay Kits 14.42.2. Instruments 14.42.2.1. Microplate Readers 14.42.2.2. Immunoassay Analyzers 14.42.2.3. Other Instruments 14.43. VietnamNeuroscience Antibodies & Assays Market Forecast, by End-user 14.43.1. Pharmaceutical & Biotechnology Companies 14.43.2. Academic & Research Institutes 14.43.3. Hospitals & Diagnostic Centers 14.44. VietnamNeuroscience Antibodies & Assays Market Forecast, By Technology 14.44.1. Immunochemistry/Immunoassays 14.44.1.1. ELISA 14.44.1.2. Western Blotting 14.44.1.3. Others Immunoassays Technologies 14.44.2. Molecular Diagnostics 14.44.3. Clinical Chemistry 14.44.4. Other Technologies 14.45. VietnamNeuroscience Antibodies & Assays Market Forecast, By Application 14.45.1. Research 14.45.2. In Vitro Diagnostics 14.45.3. Drug Discovery and Development 14.46. Asia Pacific Neuroscience Antibodies & Assays Market Attractiveness Analysis 14.46.1. By Product 14.46.2. By End-user 14.46.3. By Technology 14.46.4. By Application 14.47. PEST Analysis 14.48. Key Trends 14.49. Key Developments 15. Middle East & Africa Neuroscience Antibodies & Assays Market Analysis 15.1. Key Findings 15.2. Middle East & Africa Neuroscience Antibodies & Assays Market Overview 15.3. Middle East & Africa Neuroscience Antibodies & Assays Market Value Share Analysis, By Product 15.4. Middle East & Africa Neuroscience Antibodies & Assays Market Forecast, By Product 15.4.1. Consumables 15.4.1.1. Reagents 15.4.1.1.1. Media & Sera 15.4.1.1.2. Stains & Dyes 15.4.1.1.3. Fixatives 15.4.1.1.4. Buffers 15.4.1.1.5. Solvents 15.4.1.1.6. Probes 15.4.1.1.7. Enzymes, Proteins, & Peptides 15.4.1.1.8. Other Reagents 15.4.1.2. Antibodies 15.4.1.2.1. Primary antibodies 15.4.1.2.2. Secondary Antibodies 15.4.1.3. Assay Kits 15.4.2. Instruments 15.4.2.1. Microplate Readers 15.4.2.2. Immunoassay Analyzers 15.4.2.3. Other Instruments 15.5. Middle East & Africa Neuroscience Antibodies & Assays Market Value Share Analysis, by End-user 15.6. Middle East & Africa Neuroscience Antibodies & Assays Market Forecast, by End-user 15.6.1. Pharmaceutical & Biotechnology Companies 15.6.2. Academic & Research Institutes 15.6.3. Hospitals & Diagnostic Centers 15.7. Middle East & Africa Neuroscience Antibodies & Assays Market Value Share Analysis, By Technology 15.8. Middle East & Africa Neuroscience Antibodies & Assays Market Forecast, By Technology 15.8.1. Immunochemistry/Immunoassays 15.8.1.1. ELISA 15.8.1.2. Western Blotting 15.8.1.3. Others Immunoassays Technologies 15.8.2. Molecular Diagnostics 15.8.3. Clinical Chemistry 15.8.4. Other Technologies 15.9. Middle East & Africa Neuroscience Antibodies & Assays Market Value Share Analysis, By Application 15.10. Middle East & Africa Neuroscience Antibodies & Assays Market Forecast, By Application 15.10.1. Research 15.10.2. In Vitro Diagnostics 15.10.3. Drug Discovery and Development 15.11. Middle East & Africa Neuroscience Antibodies & Assays Market Value Share Analysis, by Country 15.12. Middle East & Africa Neuroscience Antibodies & Assays Market Forecast, by Country 15.12.1. GCC 15.12.2. South Africa 15.12.3. Nigeria 15.12.4. Egypt 15.13. Middle East & Africa Neuroscience Antibodies & Assays Market Analysis, by Country 15.14. GCC Neuroscience Antibodies & Assays Market Forecast, By Product 15.14.1. Consumables 15.14.1.1. Reagents 15.14.1.1.1. Media & Sera 15.14.1.1.2. Stains & Dyes 15.14.1.1.3. Fixatives 15.14.1.1.4. Buffers 15.14.1.1.5. Solvents 15.14.1.1.6. Probes 15.14.1.1.7. Enzymes, Proteins, & Peptides 15.14.1.1.8. Other Reagents 15.14.1.2. Antibodies 15.14.1.2.1. Primary antibodies 15.14.1.2.2. Secondary Antibodies 15.14.1.3. Assay Kits 15.14.2. Instruments 15.14.2.1. Microplate Readers 15.14.2.2. Immunoassay Analyzers 15.14.2.3. Other Instruments 15.15. GCC Neuroscience Antibodies & Assays Market Forecast, by End-user 15.15.1. Pharmaceutical & Biotechnology Companies 15.15.2. Academic & Research Institutes 15.15.3. Hospitals & Diagnostic Centers 15.16. GCC Neuroscience Antibodies & Assays Market Forecast, By Technology 15.16.1. Immunochemistry/Immunoassays 15.16.1.1. ELISA 15.16.1.2. Western Blotting 15.16.1.3. Others Immunoassays Technologies 15.16.2. Molecular Diagnostics 15.16.3. Clinical Chemistry 15.16.4. Other Technologies 15.17. GCC Neuroscience Antibodies & Assays Market Forecast, By Application 15.17.1. Research 15.17.2. In Vitro Diagnostics 15.17.3. Drug Discovery and Development 15.18. South Africa Neuroscience Antibodies & Assays Market Forecast, By Product 15.18.1. Consumables 15.18.1.1. Reagents 15.18.1.1.1. Media & Sera 15.18.1.1.2. Stains & Dyes 15.18.1.1.3. Fixatives 15.18.1.1.4. Buffers 15.18.1.1.5. Solvents 15.18.1.1.6. Probes 15.18.1.1.7. Enzymes, Proteins, & Peptides 15.18.1.1.8. Other Reagents 15.18.1.2. Antibodies 15.18.1.2.1. Primary antibodies 15.18.1.2.2. Secondary Antibodies 15.18.1.3. Assay Kits 15.18.2. Instruments 15.18.2.1. Microplate Readers 15.18.2.2. Immunoassay Analyzers 15.18.2.3. Other Instruments 15.19. South Africa Neuroscience Antibodies & Assays Market Forecast, by End-user 15.19.1. Pharmaceutical & Biotechnology Companies 15.19.2. Academic & Research Institutes 15.19.3. Hospitals & Diagnostic Centers 15.20. South Africa Neuroscience Antibodies & Assays Market Forecast, By Technology 15.20.1. Immunochemistry/Immunoassays 15.20.1.1. ELISA 15.20.1.2. Western Blotting 15.20.1.3. Others Immunoassays Technologies 15.20.2. Molecular Diagnostics 15.20.3. Clinical Chemistry 15.20.4. Other Technologies 15.21. South Africa Neuroscience Antibodies & Assays Market Forecast, By Application 15.21.1. Research 15.21.2. In Vitro Diagnostics 15.21.3. Drug Discovery and Development 15.22. NigeriaNeuroscience Antibodies & Assays Market Forecast, By Product 15.22.1. Consumables 15.22.1.1. Reagents 15.22.1.1.1. Media & Sera 15.22.1.1.2. Stains & Dyes 15.22.1.1.3. Fixatives 15.22.1.1.4. Buffers 15.22.1.1.5. Solvents 15.22.1.1.6. Probes 15.22.1.1.7. Enzymes, Proteins, & Peptides 15.22.1.1.8. Other Reagents 15.22.1.2. Antibodies 15.22.1.2.1. Primary antibodies 15.22.1.2.2. Secondary Antibodies 15.22.1.3. Assay Kits 15.22.2. Instruments 15.22.2.1. Microplate Readers 15.22.2.2. Immunoassay Analyzers 15.22.2.3. Other Instruments 15.23. NigeriaNeuroscience Antibodies & Assays Market Forecast, by End-user 15.23.1. Pharmaceutical & Biotechnology Companies 15.23.2. Academic & Research Institutes 15.23.3. Hospitals & Diagnostic Centers 15.24. NigeriaNeuroscience Antibodies & Assays Market Forecast, By Technology 15.24.1. Immunochemistry/Immunoassays 15.24.1.1. ELISA 15.24.1.2. Western Blotting 15.24.1.3. Others Immunoassays Technologies 15.24.2. Molecular Diagnostics 15.24.3. Clinical Chemistry 15.24.4. Other Technologies 15.25. NigeriaNeuroscience Antibodies & Assays Market Forecast, By Application 15.25.1. Research 15.25.2. In Vitro Diagnostics 15.25.3. Drug Discovery and Development 15.26. EgyptNeuroscience Antibodies & Assays Market Forecast, By Product 15.26.1. Consumables 15.26.1.1. Reagents 15.26.1.1.1. Media & Sera 15.26.1.1.2. Stains & Dyes 15.26.1.1.3. Fixatives 15.26.1.1.4. Buffers 15.26.1.1.5. Solvents 15.26.1.1.6. Probes 15.26.1.1.7. Enzymes, Proteins, & Peptides 15.26.1.1.8. Other Reagents 15.26.1.2. Antibodies 15.26.1.2.1. Primary antibodies 15.26.1.2.2. Secondary Antibodies 15.26.1.3. Assay Kits 15.26.2. Instruments 15.26.2.1. Microplate Readers 15.26.2.2. Immunoassay Analyzers 15.26.2.3. Other Instruments 15.27. EgyptNeuroscience Antibodies & Assays Market Forecast, by End-user 15.27.1. Pharmaceutical & Biotechnology Companies 15.27.2. Academic & Research Institutes 15.27.3. Hospitals & Diagnostic Centers 15.28. EgyptNeuroscience Antibodies & Assays Market Forecast, By Technology 15.28.1. Immunochemistry/Immunoassays 15.28.1.1. ELISA 15.28.1.2. Western Blotting 15.28.1.3. Others Immunoassays Technologies 15.28.2. Molecular Diagnostics 15.28.3. Clinical Chemistry 15.28.4. Other Technologies 15.29. EgyptNeuroscience Antibodies & Assays Market Forecast, By Application 15.29.1. Research 15.29.2. In Vitro Diagnostics 15.29.3. Drug Discovery and Development 15.30. Middle East & Africa Neuroscience Antibodies & Assays Market Attractiveness Analysis 15.30.1. By Product 15.30.2. By End-user 15.30.3. By Technology 15.30.4. By Application 15.31. PEST Analysis 15.32. Key Trends 15.33. Key Developments 16. South America Neuroscience Antibodies & Assays Market Analysis 16.1. Key Findings 16.2. South America Neuroscience Antibodies & Assays Market Overview 16.3. South America Neuroscience Antibodies & Assays Market Value Share Analysis, By Product 16.4. South America Neuroscience Antibodies & Assays Market Forecast, By Product 16.4.1. Consumables 16.4.1.1. Reagents 16.4.1.1.1. Media & Sera 16.4.1.1.2. Stains & Dyes 16.4.1.1.3. Fixatives 16.4.1.1.4. Buffers 16.4.1.1.5. Solvents 16.4.1.1.6. Probes 16.4.1.1.7. Enzymes, Proteins, & Peptides 16.4.1.1.8. Other Reagents 16.4.1.2. Antibodies 16.4.1.2.1. Primary antibodies 16.4.1.2.2. Secondary Antibodies 16.4.1.3. Assay Kits 16.4.2. Instruments 16.4.2.1. Microplate Readers 16.4.2.2. Immunoassay Analyzers 16.4.2.3. Other Instruments 16.5. South America Neuroscience Antibodies & Assays Market Value Share Analysis, by End-user 16.6. South America Neuroscience Antibodies & Assays Market Forecast, by End-user 16.6.1. Pharmaceutical & Biotechnology Companies 16.6.2. Academic & Research Institutes 16.6.3. Hospitals & Diagnostic Centers 16.7. South America Neuroscience Antibodies & Assays Market Value Share Analysis, By Technology 16.8. South America Neuroscience Antibodies & Assays Market Forecast, By Technology 16.8.1. Immunochemistry/Immunoassays 16.8.1.1. ELISA 16.8.1.2. Western Blotting 16.8.1.3. Others Immunoassays Technologies 16.8.2. Molecular Diagnostics 16.8.3. Clinical Chemistry 16.8.4. Other Technologies 16.9. South America Neuroscience Antibodies & Assays Market Value Share Analysis, By Application 16.10. South America Neuroscience Antibodies & Assays Market Forecast, By Application 16.10.1. Research 16.10.2. In Vitro Diagnostics 16.10.3. Drug Discovery and Development 16.11. South America Neuroscience Antibodies & Assays Market Value Share Analysis, by Country 16.12. South America Neuroscience Antibodies & Assays Market Forecast, by Country 16.12.1. Brazil 16.12.2. Mexico 16.12.3. Argentina 16.13. South America Neuroscience Antibodies & Assays Market Analysis, by Country 16.14. Brazil Neuroscience Antibodies & Assays Market Forecast, By Product 16.14.1. Consumables 16.14.1.1. Reagents 16.14.1.1.1. Media & Sera 16.14.1.1.2. Stains & Dyes 16.14.1.1.3. Fixatives 16.14.1.1.4. Buffers 16.14.1.1.5. Solvents 16.14.1.1.6. Probes 16.14.1.1.7. Enzymes, Proteins, & Peptides 16.14.1.1.8. Other Reagents 16.14.1.2. Antibodies 16.14.1.2.1. Primary antibodies 16.14.1.2.2. Secondary Antibodies 16.14.1.3. Assay Kits 16.14.2. Instruments 16.14.2.1. Microplate Readers 16.14.2.2. Immunoassay Analyzers 16.14.2.3. Other Instruments 16.15. Brazil Neuroscience Antibodies & Assays Market Forecast, by End-user 16.15.1. Pharmaceutical & Biotechnology Companies 16.15.2. Academic & Research Institutes 16.15.3. Hospitals & Diagnostic Centers 16.16. Brazil Neuroscience Antibodies & Assays Market Forecast, By Technology 16.16.1. Immunochemistry/Immunoassays 16.16.1.1. ELISA 16.16.1.2. Western Blotting 16.16.1.3. Others Immunoassays Technologies 16.16.2. Molecular Diagnostics 16.16.3. Clinical Chemistry 16.16.4. Other Technologies 16.17. Brazil Neuroscience Antibodies & Assays Market Forecast, By Application 16.17.1. Research 16.17.2. In Vitro Diagnostics 16.17.3. Drug Discovery and Development 16.18. Mexico Neuroscience Antibodies & Assays Market Forecast, By Product 16.18.1. Consumables 16.18.1.1. Reagents 16.18.1.1.1. Media & Sera 16.18.1.1.2. Stains & Dyes 16.18.1.1.3. Fixatives 16.18.1.1.4. Buffers 16.18.1.1.5. Solvents 16.18.1.1.6. Probes 16.18.1.1.7. Enzymes, Proteins, & Peptides 16.18.1.1.8. Other Reagents 16.18.1.2. Antibodies 16.18.1.2.1. Primary antibodies 16.18.1.2.2. Secondary Antibodies 16.18.1.3. Assay Kits 16.18.2. Instruments 16.18.2.1. Microplate Readers 16.18.2.2. Immunoassay Analyzers 16.18.2.3. Other Instruments 16.19. Mexico Neuroscience Antibodies & Assays Market Forecast, by End-user 16.19.1. Pharmaceutical & Biotechnology Companies 16.19.2. Academic & Research Institutes 16.19.3. Hospitals & Diagnostic Centers 16.20. Mexico Neuroscience Antibodies & Assays Market Forecast, By Technology 16.20.1. Immunochemistry/Immunoassays 16.20.1.1. ELISA 16.20.1.2. Western Blotting 16.20.1.3. Others Immunoassays Technologies 16.20.2. Molecular Diagnostics 16.20.3. Clinical Chemistry 16.20.4. Other Technologies 16.21. Mexico Neuroscience Antibodies & Assays Market Forecast, By Application 16.21.1. Research 16.21.2. In Vitro Diagnostics 16.21.3. Drug Discovery and Development 16.22. ArgentinaNeuroscience Antibodies & Assays Market Forecast, By Product 16.22.1. Consumables 16.22.1.1. Reagents 16.22.1.1.1. Media & Sera 16.22.1.1.2. Stains & Dyes 16.22.1.1.3. Fixatives 16.22.1.1.4. Buffers 16.22.1.1.5. Solvents 16.22.1.1.6. Probes 16.22.1.1.7. Enzymes, Proteins, & Peptides 16.22.1.1.8. Other Reagents 16.22.1.2. Antibodies 16.22.1.2.1. Primary antibodies 16.22.1.2.2. Secondary Antibodies 16.22.1.3. Assay Kits 16.22.2. Instruments 16.22.2.1. Microplate Readers 16.22.2.2. Immunoassay Analyzers 16.22.2.3. Other Instruments 16.23. ArgentinaNeuroscience Antibodies & Assays Market Forecast, by End-user 16.23.1. Pharmaceutical & Biotechnology Companies 16.23.2. Academic & Research Institutes 16.23.3. Hospitals & Diagnostic Centers 16.24. ArgentinaNeuroscience Antibodies & Assays Market Forecast, By Technology 16.24.1. Immunochemistry/Immunoassays 16.24.1.1. ELISA 16.24.1.2. Western Blotting 16.24.1.3. Others Immunoassays Technologies 16.24.2. Molecular Diagnostics 16.24.3. Clinical Chemistry 16.24.4. Other Technologies 16.25. ArgentinaNeuroscience Antibodies & Assays Market Forecast, By Application 16.25.1. Research 16.25.2. In Vitro Diagnostics 16.25.3. Drug Discovery and Development 16.26. South America Neuroscience Antibodies & Assays Market Attractiveness Analysis 16.26.1. By Product 16.26.2. By End-user 16.26.3. By Technology 16.26.4. By Application 16.27. PEST Analysis 16.28. Key Trends 16.29. Key Developments 17. Company Profiles 17.1. Market Share Analysis, by Company 17.2. Competition Matrix 17.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 17.2.2. New Product Launches and Product Enhancements 17.2.3. Market Consolidation 17.2.3.1. M&A by Regions, Investment and Applications 17.2.3.2. M&A Key Players, Forward Integration and Backward Integration 17.3. Company Profiles: Key Players 17.3.1. Thermo Fisher Scientific 17.3.1.1. Company Overview 17.3.1.2. Financial Overview 17.3.1.3. Product Portfolio 17.3.1.4. Business Strategy 17.3.1.5. Recent Developments 17.3.1.6. Development Footprint 17.3.2. Abcam 17.3.3. Bio-Rad 17.3.4. Merck KGaA 17.3.5. BioLegend 17.3.6. Cell Signaling Technology 17.3.7. F. Hoffmann-La Roche 17.3.8. GenScript 17.3.9. Rockland Immunochemicals 17.3.10. Santa Cruz Biotechnology 17.3.11. Siemens 17.3.12. Tecan 17.3.13. Others 18. Primary Key Insights

About This Report

Report ID 79832
Category Healthcare
Published Date Dec 2020
Updated Date
Contact Us